Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement

Recruiting now · Not applicable

Conditions studied: Deafness Neurosensory

In brief

Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.

Key facts

Study ID

NCT05985473

Run by

Institut Pasteur

People needed

40

Starts

2024-03-06

Expected to finish

2026-09-15

Last updated by the study team

2024-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• For all participants:
• Age greater than or equal to 18 years,
• French mother tongue,
• Have an average tonal hearing loss (calculated according to the BIAP method) < 30 dB HL, on headphones, for each ear,
• Be professionally active, not be pre-retired and not be unemployed
• Be affiliated with a social security plan,
• For participants with TSNA:
• Have degraded comprehension in noise (threshold of Intelligibility in Noise > 3 dB compared to the norm).
• For controls:
• Have normal comprehension in noise (Intelligibility in Noise threshold ≤ 3 dB from the norm).

You may not qualify if…

• For all participants:
• Have a conductive or mixed hearing loss, which is when the hearing loss affects both the outer and/or middle ear and the inner ear.
• Have an asymmetric hearing loss, i.e. a difference in average hearing loss between the left and right ear greater than 30 dB,
• Have sequelae of ear infections and/or a history of ENT disease that permanently affects hearing (vestibular schwannoma, Meniere's disease, sudden or fluctuating deafness, congenital hypoacusis)
• Being under guardianship,
• Being deprived of liberty by judicial or administrative decision, or being subject to legal protection.

Where it is running

• CEntre de Recherche et d'Innovation en Audiologie Humaine — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.